Physician profile
Brook Powell Nelson
NPI 1366731200
$14,110.37
in general payments reported to CMS, 2019-2025
63 companies · $3,329 in 2025
The $3,329 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,559 · 2022: $2,035 · 2023: $2,925 · 2024: $3,262 · 2025: $3,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,516.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,229.10 | 2021-2025 | |
| Novo Nordisk INC | $1,274.84 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $984.79 | 2021-2025 | Rexulti, Jynarque, Nuedexta |
| Pfizer INC. | $888.02 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $765.00 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $720.55 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $603.08 | 2021-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $540.84 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lundbeck LLC | $493.54 | 2021-2025 | Rexulti, Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $403.27 | 2021-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $357.24 | 2021-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $327.56 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Mylan Specialty L.P. | $316.32 | 2021-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.75 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $301.32 | 2021-2025 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $285.76 | 2022-2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $265.05 | 2021-2025 | Spravato |
| Phathom Pharmaceuticals, INC. | $240.29 | 2024-2025 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $196.49 | 2024-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $184.52 | 2021-2024 | Eliquis |
| Vanda Pharmaceuticals INC. | $156.78 | 2024-2025 | Fanapt, Hetlioz |
| Astellas Pharma US INC | $149.48 | 2021-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $145.54 | 2022 | |
| Aimmune Therapeutics, INC. | $132.52 | 2024-2025 | Zenpep |
| Currax Pharmaceuticals LLC | $129.08 | 2021-2024 | Contrave, Onzetra Xsail |
| Nestle Healthcare Nutrition INC. | $115.34 | 2021-2023 | |
| Dexcom, INC. | $108.80 | 2021-2024 | Dexcom G6 Transmitter |
| Ardelyx, INC. | $105.35 | 2024-2025 | Ibsrela |
| Eisai INC. | $104.31 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $93.93 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $91.33 | 2021 | |
| Esperion Therapeutics, INC. | $87.53 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $80.41 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $80.38 | 2021-2023 | |
| Biogen, INC. | $78.19 | 2021-2022 | |
| Alkermes, INC. | $76.78 | 2023 | Lybalvi, Aristada |
| Ironwood Pharmaceuticals, INC | $75.00 | 2021-2024 | |
| Exact Sciences Corporation | $60.24 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $49.52 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $46.37 | 2022-2023 | Quviviq |
| Corium, LLC | $43.56 | 2022-2023 | Adlarity |
| Amarin Pharma, INC. | $32.33 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $31.85 | 2024 | |
| Ani Pharmaceuticals, INC. | $31.30 | 2025 | Purified Cortrophin Gel |
| Phadia US INC. | $30.06 | 2024 | Immunocap |
| Seqirus USA INC | $29.08 | 2022-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Medtronic, INC. | $27.82 | 2022-2025 | Synchromedii |
| Ars Pharmaceuticals Operations, INC. | $22.64 | 2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $20.06 | 2025 | Ajovy |
| Genentech USA, INC. | $16.82 | 2021 | |
| Tandem Diabetes Care, INC. | $16.69 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Tactile Systems Technology INC | $16.25 | 2024 | Flexitouch Plus, Entre Plus |
| Kowa Pharmaceuticals America, INC. | $15.97 | 2025 | Zoryve |
| Organon LLC | $15.90 | 2024 | |
| Recordati_rare_diseases_inc. | $15.18 | 2025 | Isturisa |
| Impel Pharmaceuticals INC. | $14.59 | 2023 | Trudhesa |
| Kaleo, INC. | $14.21 | 2022 | |
| Sanofi Pasteur INC. | $14.08 | 2023 | |
| Axonics, INC. | $13.57 | 2022 | |
| Vifor Pharma, INC. | $12.04 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.30 | 2023 | Lifevest |
| Supernus Pharmaceuticals, INC. | $11.12 | 2021 | |
| Metacel Pharmaceuticals LLC | $7.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brook Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.